Stocks look set to continue last week’s selloff on fears that the failure to pass the Republicans health-care bill could jeopardize Donald J. Trump’s pro-growth agenda.
Agence France-Presse/Getty Images
S&P 500 futures have dropped 0.8%, while Dow Jones Industrial Average futures have declined 141 points, or 0.7%. Nasdaq Composite futures have fallen 0.8%.
CEO of Monro Muffler Brake Inc (NASDAQ:MNRO) Heel John W Van sold 129,089 shares of MNRO on 07/26/2017 at an average price of $46.76 a share. The total sale was $6 million.
Monro Muffler Brake Inc provides automotive undercar repair and tire services in the United States. The Company provides a broad range of services on passenger cars, light trucks and vans for brakes; mufflers and exhaust....More>>>
This analysis will show why we think OpenText (OTEX) is one of the few undervalued companies in the technology sector. Per the fiscal 2017 annual report, OpenText made progress expanding into the enterprise information management such that the company sees a total addressable market size of $35 billion. Given the overall market size and associated need of enterprise information management, OpenText....More>>>
For the past few years, I’ve been watching an important consolidation pattern in the U.S. dollar because I believed that another major move would likely occur when the dollar finally broke out. The U.S. Dollar Index finally launched a bullish breakout due to optimism about Donald Trump’s election win and higher expectations for future U.S. economic growth, inflation, and interest....More>>>
Many investors who watched Fitbit (NYSE:FIT) and GoPro (NASDAQ:GPRO) crash and burn may believe that demand for wearable devices — like fitness trackers and action cameras — is fading. Indeed, earlier estimates for these markets were far too bullish.
Back in 2014, Morgan Stanley estimated thatApple would sell up to 60 million Apple Watches in the first year. The actual number,....More>>>
Shares of oil stocks plunged again as the price of West Texas Intermediate wiped out nearly half of its late-January rebound. Sluggish demand growth and stubbornly high supply has had investors whipsawed for months.
In all the confusion, it is difficult not to look at the long-term picture and be positive on oil and shares of energy companies. The dramatic cut in the North American rig....More>>>
Perrigos(PRGO)CEO Joseph Papa recently left to become head of Valeant Pharmaceuticals(VRX)this week. Perrigo veteran JohnHendrickson will take over the helm of Perrigo, and time will tell if this is a positive move, according to Jefferies David Steinberg. But he doesnt think investors should wait around to find out.
Steinberg and his team today downgraded Perrigo from....More>>>
Over the past week the Dow hit an all-time high on the back of this earnings season, and the S&P 500 was within a few points of its record. However, one industry in particular has been holding back this rally. Retail stocks have lagged the market in 2017 thus far. We are reaching the point in the earnings season when most big retail companies will report, and this has the potential....More>>>
SEOUL–South Korean exports–a bellwether for global trade–rose for a fourth straight month in February on brisk demand overseas. Shipment growth was faster than expected.
Exports rose 20.2% from a year earlier to $43.19 billion in February after the prior month’s 11.2% gain, according to preliminary data from the trade ministry and the customs office. The latest reading....More>>>
Vertex Pharmaceuticals (VRTX) fell to the bottom of the S&P 500 today, earning the title of the Biggest Loser.
Shares of Vertex Pharmaceuticals fell 4.7% to $81.61 today, while the S&P 500 declined 0.3% to 2,198.81.
Yesterday, Barclays analystGeoff Meacham and team cut Vertex Pharmaceuticals to Equal Weight from Overweight. They explain why: